Document ID: chunk:federal_register_of_legislation:F2018L00001:reg:9
Version: federal_register_of_legislation:F2018L00001
Segment Type: reg
Provision Reference: reg 9
Character Range: 3934–6162

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the cerebral meninges or death from malignant neoplasm of the cerebral meninges with the circumstances of a person's relevant service:
(1)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the brain at least five years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(2)          being overweight or obese for at least five years within the 20 years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(3)          being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical onset of malignant neoplasm of the cerebral meninges;
(4)          being treated with a drug as specified within the ten years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: being treated with a drug as specified is defined in the Schedule 1 - Dictionary.
(5)          using hormone replacement therapy for a continuous period of at least six months before the clinical onset of malignant neoplasm of the cerebral meninges, and where the use of hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the cerebral meninges has occurred within ten years of cessation;
Note: hormone replacement therapy is defined in the Schedule 1 - Dictionary.
(6)          being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical worsening of malignant neoplasm of the cerebral meninges;
(7)          being treated with a drug as specified within the ten years before the clinical worsening of malignant neoplasm of the cerebral meninges;
Note: being treated with a drug as specified is defined in the Schedule 1 - Dictionary.
(8)          inability to obtain appropriate clinical management for malignant neoplasm of the cerebral meninges.